Suppr超能文献

结肠直肠癌细胞衍生的微小RNA200在体外调节相邻血内皮屏障的抗性。

Colorectal cancer cell-derived microRNA200 modulates the resistance of adjacent blood endothelial barriers in vitro.

作者信息

Holzner Silvio, Senfter Daniel, Stadler Serena, Staribacher Anna, Nguyen Chi Huu, Gaggl Anna, Geleff Silvana, Huttary Nicole, Krieger Sigurd, Jäger Walter, Dolznig Helmut, Mader Robert M, Krupitza Georg

机构信息

Clinical Institute of Pathology, Medical University of Vienna, A‑1090 Vienna, Austria.

Department of Medicine I, Comprehensive Cancer Centre, Medical University of Vienna, A‑1090 Vienna, Austria.

出版信息

Oncol Rep. 2016 Nov;36(5):3065-3071. doi: 10.3892/or.2016.5114. Epub 2016 Sep 20.

Abstract

Since cancer cells, when grown as spheroids, display drug sensitivity and radiation resistance patterns such as seen in vivo we recently established a three‑dimensional (3D) in vitro model recapitulating colorectal cancer (CRC)-triggered lymphatic endothelial cell (LEC)‑barrier breaching to study mechanisms of intra‑/extravasation. CRC metastasizes not only through lymphatics but also through blood vessels and here we extend the 3D model to the interaction of blood endothelial cells (BECs) with naïve and 5‑fluorouracil (5‑FU)‑resistant CRC CCL227 cells. The 3D model enabled quantifying effects of tumour‑derived microRNA200 (miR200) miR200a, miR200b, miR200c, miR141 and miR429 regarding the induction of so-called 'circular chemorepellent‑induced defects' (CCIDs) within the BEC‑barrier, which resemble gates for tumour transmigration. For this, miR200 precursors were individually transfected and furthermore, the modulation of ZEB family expression was analysed by western blotting. miR200c, miR141 and miR429, which are contained in exosomes from naïve CCL227 cells, downregulated the expression of ZEB2, SNAI and TWIST in BECs. The exosomes of 5‑FU‑resistant CCL227‑RH cells, which are devoid of miR200, accelerated CCID formation in BEC monolayers as compared to exosomes from naïve CCL227 cells. This confirmed the reported role of ZEB2 and SNAI in CRC metastasis and highlighted the active contribution of the stroma in the metastatic process. CCL227 spheroids affected the integrity of BEC and LEC barriers alike, which was in agreement with the observation that CRC metastasizes via blood stream (into the liver) as well as via lymphatics (into lymph nodes and lungs). This further validated the CRC/LEC and CRC/BEC in vitro model to study mechanisms of CRC spreading through vascular systems. Treatment of CCL227‑RH cells with the HDAC inhibitors mocetinostat and sulforaphane reduced CCID formation to the level triggered by naïve CCL227 spheroids, however, without significantly influencing miR200 expression in CCL227-RH cells.

摘要

由于癌细胞在形成球体生长时,会表现出在体内所观察到的药物敏感性和抗辐射模式,我们最近建立了一种三维(3D)体外模型,该模型可重现结直肠癌(CRC)引发的淋巴管内皮细胞(LEC)屏障破坏,以研究肿瘤内/外渗机制。CRC不仅通过淋巴管转移,还通过血管转移,在此我们将3D模型扩展至血管内皮细胞(BEC)与未处理的及对5-氟尿嘧啶(5-FU)耐药的CRC CCL227细胞之间的相互作用。该3D模型能够量化肿瘤来源的微小RNA200(miR200)即miR200a、miR200b、miR200c、miR141和miR429对BEC屏障内所谓“环形化学排斥诱导缺陷”(CCID)诱导的影响,这些缺陷类似于肿瘤迁移的通道。为此,分别转染了miR200前体,此外,通过蛋白质印迹法分析了ZEB家族表达的调节情况。未处理的CCL227细胞外泌体中所含的miR200c、miR141和miR429下调了BEC中ZEB2、SNAI和TWIST的表达。与未处理的CCL227细胞外泌体相比,不含miR200的5-FU耐药CCL227-RH细胞的外泌体加速了BEC单层中CCID的形成。这证实了ZEB2和SNAI在CRC转移中的作用,并突出了基质在转移过程中的积极作用。CCL227球体对BEC和LEC屏障的完整性均有影响,这与CRC通过血流(转移至肝脏)以及通过淋巴管(转移至淋巴结和肺)转移的观察结果一致。这进一步验证了CRC/LEC和CRC/BEC体外模型在研究CRC通过血管系统扩散机制方面的有效性。用组蛋白去乙酰化酶抑制剂莫西司他和萝卜硫素处理CCL227-RH细胞可将CCID形成减少至未处理的CCL227球体引发的水平,然而,这并未显著影响CCL227-RH细胞中miR200的表达。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验